Margarita N. Ryabova

Margarita N. Ryabova

Auto-generated profile, based on publicly available information

Margarita N. Ryabova

Ryazan State Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
RURyazan State Medical University
Ryazan State Medical University
MRM. N. Ryabova
M. N. Ryabova
ASA. V. Seleznev
A. V. Seleznev
IFI. A. Fokin
I. A. Fokin
DSD. R. Shodiyev
D. R. Shodiyev
MDM. N. Dmitriyeva
M. N. Dmitriyeva
INTRODUCTION: Hyaluronic acid (HA) is a natural glycosaminoglycan which is an integral component of both the matrix of articular cartilage and synovial fluid with its unique rheological properties that are lost in gonarthrosis, which leads to a decrease of viscoelastic characteristics of the synovia and destruction of the cartilage. AIM: To evaluate the effectiveness and safety of the use of Hyapro sterile biopolymer synovial fluid prosthesis in a disposable syringe for intra-articular injection at a concentration of 1.5% — 2 ml in treatment of gonarthrosis. MATERIALS AND METHODS: From September 2020 to April 2022 at settings of the orthopedic department of Ryazan Regional Clinical Hospital, an open prospective non-comparative study of the effectiveness and safety of Hyapro sterile biopolymer synovial fluid prosthesis at a concentration of 1.5% — 2 ml in 30 patients with 2 to 3 stage gonarthrosis according to Kellgren–Lawrence scale was carried out. Prior to the treatment, and also 3 and 6 months after, the severity of clinical symptoms on VAS, WOMAC, Leken scales, the quality of life according to SF-36 questionnaire were registered; the biochemical markers namely cartilaginous oligomatrix peptide (COMP), metal matrix proteinase 3 (MMR 3) were determined with the use of StatFax enzyme-linked plate analyzer (Awareness Technology, USA). RESULTS: In general, the studied drug was well tolerated by patients: there were no typical for intra-articular injections cases of clinically important adverse reactions like prolonged pain at the injection site, expansion-like sensation, an elevation of local temperature, and changes in the color of skin or changes of the shape of the knee joint. Just transient local tenderness in 6.7% of injection cases was noted. We revealed a statistically significant decrease in serum MMR-3 levels by 6 months of follow-up, which reflects a reduction of the inflammatory component in osteoarthritis of the joint studied. Besides, a gradual increase in COMP levels by the 6th month of the study was found, which may be an evidence of activation of the protein after the course of treatment to replenish the cartilage matrix. The results on VAS, WOMAC scales, and Leken algofunctional index demonstrated similar positive dynamics: a statistically reliable decrease in such parameters as pain, stiffness, and impaired functioning by the 3rd month of follow-up compared with the initial level; this trend was remaining in 6 months. After 3 months of treatment, there was a reliable improvement of the quality of life on the subscale of the physical component of health compared with the initial level, which persisted until the end of the study. On the subscale of the psychological component of health, no changes were found during the period. CONCLUSION: The course use of Hyapro biopolymer synovial fluid prosthesis on the basis of hyaluronic acid thermally stabilized with mannitol, in symptomatic gonarthrosis of intermediate stages, permits safely and effectively reduce pain and the inflammatory response, improve the function of the affected joint through restoration of viscoelastic and protective properties of synovial fluid for up to at least 6 months, improving the quality of life of patients.

6 June 2023 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
DSD. R. Shodiev
D. R. Shodiev
VZValentina I. Zvyagina
Valentina I. Zvyagina
MRM. N. Ryabova
M. N. Ryabova
MDM. N. Dmitrieva
M. N. Dmitrieva
BACKGROUND: Currently, OA is considered a polyetiological disease, where several phenotypes are distinguished based on the leading role of a specific risk factor. It is assumed that each clinical phenotype corresponds to its own fundamental changes in various organs and systems. Modern experimental evidence of chondro-osteogenic activity allows us to consider melatonin as a potential drug for various types of osteoarticular pathology.AIM: To study clinical and biochemical changes and effects of melatonin in the metabolic phenotype of OA and insomnia.MATERIALS AND METHODS: The study involved patients with a metabolic phenotype of OA and healthy volunteers. The subjects were collected complaints and anamnesis, as well as general clinical and orthopedic examination. In the blood serum, markers of bone and cartilage metabolism were determined. Patients were asked to answer the questions of clinical scales to assess the quality of sleep, the functional state of the joints and quality of life.RESULTS: The study involved 36 patients. Participants were divided into 3 groups: group health patients — patients without articular pathology, sleep quality disorders and normal body mass index; control group- patients with metabolic phenotype of OA, insomnia and basic treatment for 30 days; experimental group — patients with a metabolic phenotype of OA and insomnia, whose basic treatment included melatonin (Melaxen®) at a dosage of 3 mg for 30 days. Statistically significant differences were observed between the initial levels of acid phosphatase (AP), bone isoenzyme alkaline phosphatase (ALP) and calcium (Ca) in the control and experimental groups. According to the results of screening for the detection of insomnia among patients with the metabolic phenotype of, there were statistically significant insomnological disorders compared to the group health patients, as well as significant differences in terms of pain, symptoms, activity and quality of life in general according to the KOOS and SF-36 scales. Correlation analysis showed moderate correlations with biochemical parameters in patients with OA metabolic phenotype groups. After the treatment there was a certain increase in the level of Ca and a decrease in the activity of ALP and АP in patients of experimental group in comparison with patients of control groups. There was a positive trend in the range of criteria of the KOOS and SF-36 scale in experimental groups, pronounced decrease in pain syndrome (P), symptoms (S) and an increase in the levels of daily activity (A) and the total indicator (Sum) in comparison with patients of control groups. Also as improved sleep quality on all scales in comparison with the control group. In control group, problems with the quality and quantity of sleep remained at the same level.CONCLUSION: In patients with the most pronounced indicators of clinical manifestations of OA, more active processes of bone remodeling. The higher the level of bone resorption markers, the greater the severity of the clinical course in patients with osteoarthritis, and the worse the quality of sleep in general. The addition of melatonin to the treatment regimen was associated with a decrease in serum activity of the bone isoenzyme of alkaline phosphatase, acid phosphatase, an increase in calcium levels, as well as with an improvement in sleep and clinical symptoms ОА.

1 September 2024 in Problems of Biological, Medical and Pharmaceutical Chemistry
Verified
Journal Article
Closed access
DSD.R. Shodiev
D.R. Shodiev
VZValentina I. Zvyagina
Valentina I. Zvyagina
MRM.N. Ryabova
M.N. Ryabova
YMYu. A. Marsyanova
Yu. A. Marsyanova
Introduction. Melatonin, by inducing the expression of antioxidant enzymes and signaling proteins, enhances the effects in the development of pathological processes occurring against the background of oxidative stress, therefore the stabilization of the protective principles of melatonin is a rel-evant area of research, allowing us to identify new ways of development and treatment of osteoarthritis. The aim. To study the effect of melatonin on the succinate receptor system of chondrocytes in osteoarthritis under conditions of oxidative stress in vitro. Materials and methods. The in vitro study was carried out on chondrocyte cell cultures. Melatonin was added to chondrocytes to obtain final con-centrations of 100 μM and 500 μM; and hydrogen peroxide (H2O2) – 200 µM. The duration of exposure was 24 hours for melatonin and 12 hours for H2O2. Succinate levels and expression of its receptor (SUCNR1) were determined in mitochondria and chondrocyte lysates. Results. It was found that the addition of H2O2 at a dose of 200 μM to the nutrient medium for 12 hours led to a fold increase in the level of succinate and SUCNR1 expression in chondrocyte cells. Pre-incubation of chondrocyte cells with melatonin at concentrations of 100 µM and 500 µM, followed by modeling of oxidative stress (H2O2 200 µM) led to a decrease in the expression of the succinate receptor system. Conclusion. When Н2О2 is added to the cellular environment of chondrocytes, high expression of SUCNR1 and an increase in succinate levels are ob-served. Melatonin treatment limits Н2О2-induced succinate accumulation and reduces SUCNR1 expression in human chondrocyte cells of the metabolic phenotype of osteoarthritis

30 June 2026 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
ASAleksandr V. Seleznev
Aleksandr V. Seleznev
IFIgor A. Fokin
Igor A. Fokin
MRMargarita N. Ryabova
Margarita N. Ryabova
SRSvetlana E. Revenko
Svetlana E. Revenko
BACKGROUND: Road traffic injuries especially when combined with arterial thrombosis are one of causes of mortality. Suppurative complications in these patients can be caused by microbial associations complicating treatment. A complete extremity loss creates significant difficulties in exoprosthetics that does not always meet the patients’ expectations. A clinical case of a severe skeletal trauma with the overall follow-up period of 8 years is described. In a road traffic accident, a 28-year-old patient sustained an open fracture of pelvic bones and a comminuted femur fracture with thrombosis of the external iliac artery. After the amputation at the level of the middle third of the thigh due to higher-level ischemia and the development of stump gangrene with purulent-necrotic phlegmon, disarticulation of the femur was required with open wound management. The peculiarities of the case, technical limitations of treatment options due to obesity, wound extent (up to 5% of the body surface) are described; stages and approaches to antibiotic therapy, a comprehensive approach to drug, infusion-transfusion therapy, correction of gastroenterological complications and of phantom pain syndrome of the lower extremity are presented. In the treatment of a purulent wound complicated by the development of post-traumatic osteomyelitis, staged necrectomy was performed, followed by skin grafting. At the third stage of rehabilitation, reconstructive skin-plastic surgery was conducted, which made it possible to perform prosthetics of the left lower limb with a modular Ottobock C-LEG prosthesis. CONCLUSION: The patent’s management required significant medical resources and the involvement of medical specialists from various fields. Therefore, the essential conditions were the formation of a multidisciplinary team, assigning doctors to the patient, their closer collaboration in the third stage of rehabilitation. The outcome of this case can be considered satisfactory: the patient achieved social adaptation, preserving an active lifestyle and a satisfactory level of health.

30 September 2023 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
ENEvgeniy A. Nazarov
Evgeniy A. Nazarov
RURyazan State Medical University
Ryazan State Medical University
AZAndrey A. Zubov
Andrey A. Zubov
MRMargarita N. Ryabova
Margarita N. Ryabova
ASAleksandr V. Seleznev
Aleksandr V. Seleznev

30 June 2022 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
AZAndrey A. Zubov
Andrey A. Zubov
RURyazan State Medical University
Ryazan State Medical University
MRMargarita N. Ryabova
Margarita N. Ryabova
YNYuliya K. Novikova
Yuliya K. Novikova
INTRODUCTION: Zudek syndrome (neuroreflex algodystrophy, accompanied by osteoporosis, limited range of motion in the wrist and interphalangeal joints, impaired blood flow and associated trophic alterations) accounts for up to 62% of complications of fracture of the distal metaepiphysis of the radius. It may be a consequence of primary action of pathological factors (I type), or may result from compression of peripheral nerves (II type). The article describes a clinical case illustrating occurrence of almost all critical errors in the treatment process (non-performance of local anesthesia of the fracture and of reposition of fragments; fixation of the hand in a vicious (for this type of fracture) flexion position for up to 3 weeks; lack of local physiotherapy, anti-inflammatory and kinesitherapeutic treatment; use of “aggressive” mechanotherapy in passive restoration of the volume of movements and of “hard” massage against the background pain syndrome) that contributed to the development of the given II type complication. As a result, a surgical correction was required — corrective osteotomy of the radius to eliminate the cause of compression of the ulnar and median nerves and restore the interrelations between the articular surfaces in the wrist joint. CONCLUSION: Non-observance of the principles of treatment of a fracture of the radius in a “typical place” (emergency care; adequate anesthesia; immediate sparing reposition; subsequent clinical and radiological control, functional management; sufficient period of immobilization; early physiotherapy and kinesitherapy; etc.) may provoke such a threatening complication as Zudek syndrome characterized by a prolonged disability and inflicting physical and moral suffering. Besides, it is associated with a high cost of treatment and restoration of the function of the damaged limb, significantly exceeding the economic standard.